Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
3.120
-0.160 (-4.88%)
Aug 1, 2025, 4:00 PM - Market closed
DFS Market Cap
Celularity has a market cap or net worth of $77.03 million as of August 1, 2025. Its market cap has increased by 8.14% in one year.
Market Cap
77.03M
Enterprise Value
145.13M
1-Year Change
8.14%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $77.03M, a decrease of -78.13%. That is a compound annual growth rate of -22.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 77.03M | 64.71% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | 395.31M | 10.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |